Annual Oxford Stem Cell Institute Symposium, 2-3 November 2026
Stem Cells: From Mechanism to Therapy
Oxford Martin School 34 Broad Street, Oxford
CANCER STEM CELLS • REPROGRAMMING • TISSUE ENGINEERING • ORGANOIDS • REGENERATIVE MEDICINE
OSCI Symposium is an international event, unifying scientists and clinicians working in stem cells research in various fields of translational medicine.
Agenda
monday 2nd november, Oxford Martin School, 34 Broad St, Oxford OX1 3BD
| Speaker | Title | Chair | |
| 9.15 | REGISTRATION | ||
| 10.10 | Welcome Colin Goding | ||
| 10.20 | Mekayla Storer, Cambridge | At the tip of regeneration | Colin Goding |
| 10.50 | Teresa Rayon, Cambridge | The role of protein metabolism on stem cell dynamics | Colin Goding |
| 11.20 | BREAK | ||
| 11.50 | Paresh Vyas, Oxford | Quantitating stem and progenitor cell clonal dynamics through differentiation using normal and malignant haemopoiesis as an exemplar | Francesco Boccellato |
| 12.20 | Vivian Li, London | Cellular plasticity in regeneration and cancer | Francesco Boccellato |
| 12.50 | Sponsor’s talk: Bio-Rad | TBC | Francesco Boccellato |
| 13.00 | LUNCH | ||
| 14.30 | Sponsor’s talk: 10x Genomics | TBC | Francis Szele |
| 14.40 | Angela Russell, Oxford | Small molecule modulators of lymphangiogenesis to stimulate cardiac regeneration following myocardial infarction | Francis Szelel |
| 15.10 | Emma Rawlins, Cambridge | Local hypoxia promotes differentiation in lung development and cell fate plasticity in disease | Francis Szele |
| 15.40 | Richard Wade-Martins, Oxford | Modelling Parkinson’s brain circuitry in human neurons in 2D and 3D systems in vitro | Francis Szele |
| 16.10 | BREAK | ||
| 16.40 | Malcolm Logan, London | Principles of building skeletal muscle tissue | Simon Leedham |
| 17.10 | Juan Pedro Martinez-Barbera, London | Senescence: The anti-cancer program that fuels cancer | Simon Leedham |
| 17.40 | END | ||
| 19.00 | SPEAKERS’ DINNER |
tuesday 3rd november, Oxford Martin School, 34 Broad St, Oxford OX1 3BD
| Speaker | Title | Chair | |
| 9.30 | ARRIVALS | ||
| 10.10 | Welcome: Francesco Boccellato | ||
| 10.20 | Beth Psaila, Oxford | First shot on goal: precision targeting of mutant stem cells in myeloproliferative neoplasms | Eric O’Neill |
| 10.50 | Joo-Hyeon Lee, New York | Reprogramming of stem cells and niches from regeneration to disease | Eric O’Neill |
| 11.20 | BREAK | ||
| 11.50 | Simon Leedham, Oxford | Wnt mutation selection in colitis-associated colorectal neoplasia- What, when and why? | Beth Psaila |
| 12.20 | Rachael Pearson, London | Stem cell therapies for retinal disease | Beth Psaila |
| 12.50 | Alastair McKee, Proteintech | HumanKine recombinant proteins: How native homology drives bioactivity | Beth Psaila |
| 13.00 | LUNCH | ||
| 14.30 | Sponsor’s talk: bit.bio | TBC | Richard White |
| 14.40 | Francesco Boccellato, Oxford | Mechanochemical YAP1–DKK1–WNT feedback regulates regenerative niche confinement in the human stomach | Richard White |
| 15.10 | Eric O’Neill, Oxford | Mechanotransduction and stem cell behaviour in cancer cells - Hippo pathway signalling | Richard White |
| 15.40 | Simón Méndez-Ferrer | TBC | Richard White |
| 16.10 | BREAK | ||
| 16.40 | Lionel Larue, Institute Curie, Paris | Context-dependent roles of Ctnnb1, Brn2, and Mitf in mouse melanocyte stem cells mediated pigmentation renewal | Paul Riley |
| 17.10 | Chris Toepfer, Oxford | Un-masking Supervillin as a novel disease gene in Hypertrophic Cardiomyopathy | Paul Riley |
| 17.40 | Closing Remarks | END OF SYMPOSIUM |
Speakers
To date the following speakers have been confirmed for the event:
Lionel Larue (Institute Curie, Paris, France)
Joo-Hyeon Lee (Memorial Sloan Kettering Cancer Centre, New York, USA)
Emma Rawlins (Cambridge Stem Cell Institute, Cambridge)
Vivian Li (The Francis Crick Institute, London)
Malcolm Logan (King's College London, London)
Teresa Rayon (Babraham Institute, Cambridge)
Simón Méndez-Ferrer (Cambridge Stem Cell Institute, Cambridge)
Juan Pedro Martinez-Barbera (University College London,)
Mekayla Storer (Cambridge Stem Cell Institute, Cambridge)
Rachael Pearson (King's College London, London)
Beth Psaila (Radcliffe Department of Medicine, University of Oxford)
Paresh Vyas (MRC, Weatheral Institute of Molecular Medicine, University of Oxford)
Simon Leedham (Centre for Human Genetics, University of Oxford)
Angela Russell (Department of Chemistry, University of Oxford)
Richard Wade-Martins (DPAG, University of Oxford)
Chris Toepfer (Radcliffe Department of Medicine, University of Oxford)
Eric O’Neill (Department of Oncology, University of Oxford)
Francesco Boccellato (Ludwig Institute for Cancer Research, University of Oxford)
WE THANK OUR SPONSORS FOR THEIR SUPPORT
